Global Cell Reprogramming Market Research Report 2024

Publication ID:

PB504251689

Publication Date:

April 16, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Cell reprogramming is听the process of reverting mature, specialised cells into induced pluripotent stem cells. Reprogramming also refers to the erasure and re-establishment of epigenetic marks during mammalian germ cell development.
The global Cell Reprogramming market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cell Reprogramming is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cell Reprogramming is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cell Reprogramming in Research & Academic Institutes is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cell Reprogramming include Allele Biotechnology, ALSTEM, Applied Biological Materials, Axol Bioscience, Creative Bioarray, DefiniGEN, Fujifilm Cellular Dynamics, Lonza and Mogrify, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell Reprogramming, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Reprogramming.
Report Scope
The Cell Reprogramming market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell Reprogramming market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Reprogramming companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allele Biotechnology
ALSTEM
Applied Biological Materials
Axol Bioscience
Creative Bioarray
DefiniGEN
Fujifilm Cellular Dynamics
Lonza
Mogrify
REPROCELL
Stemnovate
Thermo Fisher Scientific
Segment by Type
Sendai virus-based Reprogramming
mRNA Reprogramming
Episomal Reprogramming
Others
Segment by Application
Research & Academic Institutes
Biotechnology & Pharmaceutical Companies
Hospitals & Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Reprogramming companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Reprogramming Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Sendai virus-based Reprogramming
1.2.3 mRNA Reprogramming
1.2.4 Episomal Reprogramming
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cell Reprogramming Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research & Academic Institutes
1.3.3 Biotechnology & Pharmaceutical Companies
1.3.4 Hospitals & Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Reprogramming Market Perspective (2019-2030)
2.2 Cell Reprogramming Growth Trends by Region
2.2.1 Global Cell Reprogramming Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell Reprogramming Historic Market Size by Region (2019-2024)
2.2.3 Cell Reprogramming Forecasted Market Size by Region (2025-2030)
2.3 Cell Reprogramming Market Dynamics
2.3.1 Cell Reprogramming Industry Trends
2.3.2 Cell Reprogramming Market Drivers
2.3.3 Cell Reprogramming Market Challenges
2.3.4 Cell Reprogramming Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Reprogramming Players by Revenue
3.1.1 Global Top Cell Reprogramming Players by Revenue (2019-2024)
3.1.2 Global Cell Reprogramming Revenue Market Share by Players (2019-2024)
3.2 Global Cell Reprogramming Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Reprogramming Revenue
3.4 Global Cell Reprogramming Market Concentration Ratio
3.4.1 Global Cell Reprogramming Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Reprogramming Revenue in 2023
3.5 Cell Reprogramming Key Players Head office and Area Served
3.6 Key Players Cell Reprogramming Product Solution and Service
3.7 Date of Enter into Cell Reprogramming Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Reprogramming Breakdown Data by Type
4.1 Global Cell Reprogramming Historic Market Size by Type (2019-2024)
4.2 Global Cell Reprogramming Forecasted Market Size by Type (2025-2030)
5 Cell Reprogramming Breakdown Data by Application
5.1 Global Cell Reprogramming Historic Market Size by Application (2019-2024)
5.2 Global Cell Reprogramming Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cell Reprogramming Market Size (2019-2030)
6.2 North America Cell Reprogramming Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cell Reprogramming Market Size by Country (2019-2024)
6.4 North America Cell Reprogramming Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Reprogramming Market Size (2019-2030)
7.2 Europe Cell Reprogramming Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cell Reprogramming Market Size by Country (2019-2024)
7.4 Europe Cell Reprogramming Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Reprogramming Market Size (2019-2030)
8.2 Asia-Pacific Cell Reprogramming Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cell Reprogramming Market Size by Region (2019-2024)
8.4 Asia-Pacific Cell Reprogramming Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Reprogramming Market Size (2019-2030)
9.2 Latin America Cell Reprogramming Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cell Reprogramming Market Size by Country (2019-2024)
9.4 Latin America Cell Reprogramming Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Reprogramming Market Size (2019-2030)
10.2 Middle East & Africa Cell Reprogramming Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cell Reprogramming Market Size by Country (2019-2024)
10.4 Middle East & Africa Cell Reprogramming Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allele Biotechnology
11.1.1 Allele Biotechnology Company Detail
11.1.2 Allele Biotechnology Business Overview
11.1.3 Allele Biotechnology Cell Reprogramming Introduction
11.1.4 Allele Biotechnology Revenue in Cell Reprogramming Business (2019-2024)
11.1.5 Allele Biotechnology Recent Development
11.2 ALSTEM
11.2.1 ALSTEM Company Detail
11.2.2 ALSTEM Business Overview
11.2.3 ALSTEM Cell Reprogramming Introduction
11.2.4 ALSTEM Revenue in Cell Reprogramming Business (2019-2024)
11.2.5 ALSTEM Recent Development
11.3 Applied Biological Materials
11.3.1 Applied Biological Materials Company Detail
11.3.2 Applied Biological Materials Business Overview
11.3.3 Applied Biological Materials Cell Reprogramming Introduction
11.3.4 Applied Biological Materials Revenue in Cell Reprogramming Business (2019-2024)
11.3.5 Applied Biological Materials Recent Development
11.4 Axol Bioscience
11.4.1 Axol Bioscience Company Detail
11.4.2 Axol Bioscience Business Overview
11.4.3 Axol Bioscience Cell Reprogramming Introduction
11.4.4 Axol Bioscience Revenue in Cell Reprogramming Business (2019-2024)
11.4.5 Axol Bioscience Recent Development
11.5 Creative Bioarray
11.5.1 Creative Bioarray Company Detail
11.5.2 Creative Bioarray Business Overview
11.5.3 Creative Bioarray Cell Reprogramming Introduction
11.5.4 Creative Bioarray Revenue in Cell Reprogramming Business (2019-2024)
11.5.5 Creative Bioarray Recent Development
11.6 DefiniGEN
11.6.1 DefiniGEN Company Detail
11.6.2 DefiniGEN Business Overview
11.6.3 DefiniGEN Cell Reprogramming Introduction
11.6.4 DefiniGEN Revenue in Cell Reprogramming Business (2019-2024)
11.6.5 DefiniGEN Recent Development
11.7 Fujifilm Cellular Dynamics
11.7.1 Fujifilm Cellular Dynamics Company Detail
11.7.2 Fujifilm Cellular Dynamics Business Overview
11.7.3 Fujifilm Cellular Dynamics Cell Reprogramming Introduction
11.7.4 Fujifilm Cellular Dynamics Revenue in Cell Reprogramming Business (2019-2024)
11.7.5 Fujifilm Cellular Dynamics Recent Development
11.8 Lonza
11.8.1 Lonza Company Detail
11.8.2 Lonza Business Overview
11.8.3 Lonza Cell Reprogramming Introduction
11.8.4 Lonza Revenue in Cell Reprogramming Business (2019-2024)
11.8.5 Lonza Recent Development
11.9 Mogrify
11.9.1 Mogrify Company Detail
11.9.2 Mogrify Business Overview
11.9.3 Mogrify Cell Reprogramming Introduction
11.9.4 Mogrify Revenue in Cell Reprogramming Business (2019-2024)
11.9.5 Mogrify Recent Development
11.10 REPROCELL
11.10.1 REPROCELL Company Detail
11.10.2 REPROCELL Business Overview
11.10.3 REPROCELL Cell Reprogramming Introduction
11.10.4 REPROCELL Revenue in Cell Reprogramming Business (2019-2024)
11.10.5 REPROCELL Recent Development
11.11 Stemnovate
11.11.1 Stemnovate Company Detail
11.11.2 Stemnovate Business Overview
11.11.3 Stemnovate Cell Reprogramming Introduction
11.11.4 Stemnovate Revenue in Cell Reprogramming Business (2019-2024)
11.11.5 Stemnovate Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Detail
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Cell Reprogramming Introduction
11.12.4 Thermo Fisher Scientific Revenue in Cell Reprogramming Business (2019-2024)
11.12.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Allele Biotechnology
ALSTEM
Applied Biological Materials
Axol Bioscience
Creative Bioarray
DefiniGEN
Fujifilm Cellular Dynamics
Lonza
Mogrify
REPROCELL
Stemnovate
Thermo Fisher Scientific

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂